Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,560.00
Bid: 4,560.00
Ask: 4,680.00
Change: 110.00 (2.44%)
Spread: 120.00 (2.632%)
Open: 4,540.00
High: 4,660.00
Low: 4,540.00
Prev. Close: 4,510.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Sep 2023 10:03

RNS Number : 8463N
Camellia PLC
27 September 2023
 

27 September 2023

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

The last quarter of the year is a critical trading period for our Group. This is due to the seasonal nature of our crops, with a substantial proportion of our tea production and sales occurring in that period in conjunction with substantive avocado and macadamia sales. While it therefore remains difficult to predict the outcome for the full year, there has been a significant deterioration in our expectations for certain of our businesses in recent weeks.

 

Tea

Kenya and Bangladesh production to the end of September is ahead of expectation. However due to weather conditions, tea production in India for the same period has been materially below expectation at only 3-4% ahead of last year and critically, this trend is now anticipated to continue for the remainder of the key cropping months. Lower production has also been experienced in Malawi due to very dry conditions experienced following cyclone Freddy in March. On a combined basis, Group tea estate production is now expected to be only c 7% ahead of prior year. Bought leaf volumes in India are also tracking below that previously expected.

 

Our average prices achieved in India and Malawi have also been substantially below expectations and market conditions suggest this is likely to continue for the remainder of the year. Prices in Kenya in September were marginally higher than expected.

 

The market for branded teas in India remains competitive. Although at Jing Tea, our UK branded business, where sales are up 15% in the year to date, lower than expected occupancy levels in the hotel and leisure sector globally continues to constrain growth.

 

Avocado

Average selling prices for our Hass crop to date have been significantly below expectations which will impact full year results. However, there are signs that market prices are recovering as we move into our peak period for deliveries into Europe.

 

Other fruits

The Gala apple harvest at Bardsley is underway with fruit quality improved on that of last season. However, the pear and Bramley crops are 25% and 40% respectively lower than expected. Much of the sales programme for the 2023 harvest is now in place with prices improved only marginally on those of last year. Price increases achieved are insufficient to fully compensate for the cost inflation experienced over the last 18 months.

 

Other crops

Average selling prices for maize and wheat have deteriorated significantly during the last few weeks as the scale of production in South America has become clearer.

 

Outlook

Despite the difficulty in forecasting, if current market pricing and production trends continue through the remainder of the year, revenue for continuing operations* for 2023 would be expected to be in the region of £283 million to £287 million with an adjusted loss before tax for continuing operations** of c£9 -11 million.

 

 

* continuing operations are all operations except for ACS&T which was sold at the end of 2022

** adjusted profit before tax for continuing operations seeks to present an indication of performance for continuing operations which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges/releases, gains/losses on disposal of assets and restructuring costs.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Byron Coombs, CEO

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGZLRNRGFZG
Date   Source Headline
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update
6th Sep 20222:45 pmRNSInterim Report 2022 - Replacement
1st Sep 20224:00 pmRNSInterim Report 2022
1st Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSTrading Update
1st Jul 202210:54 amRNSResults of Annual General Meeting - 30 June 2022
30th Jun 20227:00 amRNSBF&M Strategic Review
30th Jun 20227:00 amRNSAGM Trading Statement
9th Jun 202211:12 amRNSBoard Committee Changes
6th Jun 20225:22 pmRNSAnnual Report and Notice of AGM
31st May 20227:00 amRNSFinal Results
6th May 20227:00 amRNSDirector Changes and Trading Update
22nd Dec 20217:00 amRNSTrading Update
17th Nov 20217:00 amRNS100% Ownership of Bardsley England
2nd Nov 20217:00 amRNSDirectorate Change
2nd Sep 20212:36 pmRNSInterim Report 2021
2nd Sep 20217:00 amRNSHalf-year Report and changes to Board Committees
25th Aug 202112:42 pmRNSNotice of Interim Results
6th Aug 20218:30 amRNSDeath of Director
5th Aug 20217:00 amRNSSale of Abbey Metal Finishing
2nd Aug 20217:00 amRNSPurchase of Bardsley England
20th Jul 20212:00 pmRNSTrading Update
3rd Jun 20214:15 pmRNSResults of Annual General Meeting - 3 June 2021
3rd Jun 202112:00 pmRNSAGM Trading Statement
5th May 20214:00 pmRNSAnnual Report and Notice of AGM
4th May 20217:00 amRNSFinal Results and Directorate change
29th Apr 20214:30 pmRNSFinal Results - Date of Announcement
11th Feb 20218:00 amRNSTrading update and settlement of claims
16th Nov 20207:00 amRNSCompletion of asset disposal
2nd Nov 20207:15 amRNSGovernance changes
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.